Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...

CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage ...

Over the past decade, the use of artificial intelligence (AI) has radically transformed the understanding and clinical approach to diabetes. Advances such ...

There could be a test to screen for type 1 diabetes after new research by scientists found early markers.

One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the ...